Construction of SCHOTT’s State-Of-The-Art Syringe Plant Is Now Underway

Construction of SCHOTT’s State-Of-The-Art Syringe Plant Is Now Underway

2022. 10. 27.


Germany-based SCHOTT’s project to build a new production hub for glass prefillable syringes (PFS) is going to plan as evidenced by the launch of the construction celebrated at a groundbreaking event in Lukácsháza located in Vas County. Thanks to the EUR 76 million investment up to 120 newly created jobs will be available.

The German SCHOTT Group produces special glassware, glass ceramics and related high-end material, with its Hungarian subsidiary, SCHOTT Hungary Kft. being the largest pharmaceutical manufacturing plant of the Group.

The company decided to add a second production hub for glass PFS to its global manufacturing network. Thus, a EUR 76 million investment is envisaged at its Lukácsháza site located in the Western part of Hungary, Vas County. The product that requires cutting-edge technology is manufactured by SCHOTT currently only at its site in Switzerland.

The new facility will use fully automated manufacturing processes, state-of-the-art machinery as well as an advanced camera-controlled inspection system.

The high-quality PFS not only offer a stable, long-term storage solution for drugs, but also a safe and convenient delivery system for patients and clinicians.

The company plans to complete the capacity expansion by 2024.